Mp381characteristics of Responders and Non-responders to Treatment With Sucroferric Oxyhydroxide: a Post Hoc Analysis of a Phase 3 Study
Year: 2016
Type: conference-abstract
Institutions: Universitätsklinikum Aachen, RWTH Aachen University, Endeavor Health, University of Chicago, University of California, Los Angeles, Klinikum Coburg, Grigore T. Popa University of Medicine and Pharmacy, Vifor Pharma (Switzerland), The University of Texas at San Antonio Health Science Center
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Keywords: sucroferric oxyhydroxide, sevelamer carbonate, hyperphosphatemia, dialysis patients, chronic kidney disease-mineral and bone disorder, treatment response, serum phosphorus, intact parathyroid hormone, fibroblast growth factor 23, medication burden, iron-based phosphate binder, dose titration, predictors of treatment response, post hoc analysis
Open Access status: closed
OpenAlex ID: W2588058970
